Mark M. Hassall is an ophthalmologist based in Bedford Park, SA, Australia. He looks after people with a wide range of eye problems, from day-to-day changes in vision to more complex conditions that need close follow-up.
His work includes eye pressure and optic nerve concerns, like glaucoma and ocular hypertension (OHT). He also helps with situations where the eye’s structure changes over time, such as pigment-dispersion syndrome, and conditions that can affect the cornea, including lattice corneal dystrophy type 2 and macular corneal dystrophy type 1.
Mark also treats retina-related issues. That can include diabetic retinopathy, late-onset retinal degeneration, and long-term conditions like retinitis pigmentosa. At times, he cares for people after events such as retinal artery occlusion, where quick assessment matters for vision and ongoing planning.
Some patients need care for inflammation and blood-vessel related eye conditions too. This can include giant cell arteritis (GCA) and temporal arteritis, as well as vasculitis. In many cases, these conditions are linked to changes outside the eye as well, so the approach usually focuses on protecting sight and coordinating care with other health services when needed.
There are also non-retina and non-corneal causes of vision worry that come up. For example, a ganglion cyst can affect the eye and its surrounding area, and Mark looks at these issues with a practical, patient-focused plan.
On the treatment side, he manages both medical and surgical care. Options can include procedures such as trabeculectomy for glaucoma and vitrectomy for certain retina problems. Cataracts are also part of his regular clinical care.
In terms of experience, he works with these types of conditions in everyday ophthalmology practice. Specific years of experience are not listed here, but the range of conditions and procedures shows he deals with both common and more complex eye problems.
Education details are not provided in the information available here. Research and clinical trials details also aren’t listed, so there’s no extra trial information to include at this stage.
